Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00861185 · ClinicalTrials.gov registry record · Phase 2
Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
A Phase 2 study, sponsored by Icagen.
- Completed
- Registry status
- Phase 2
- Development phase
- 69
- Enrollment target
NCT00861185 is a Phase 2 study that has completed, run by Icagen. The registered enrollment target is 69 participants.
The verdict
NCT00861185, a Phase 2 study, has completed, sponsored by Icagen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether 4 weeks of dosing with senicapoc alleviates exercise induced asthma symptoms.
Interventions
- DRUG Placebo
- DRUG senicapoc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00861185
The ClinicalTrials.gov registry entry for NCT00861185 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icagen, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00861185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00861185 about?
NCT00861185 is a clinical study titled "Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma". The purpose of this study is to determine whether 4 weeks of dosing with senicapoc alleviates exercise induced asthma symptoms.
What is the current status of trial NCT00861185?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 69 participants. The study started on 2009-03. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00861185?
The interventions under investigation include: Placebo (DRUG), senicapoc (DRUG).
Who is sponsoring clinical trial NCT00861185?
This trial is sponsored by Icagen, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.